PROCEPT BioRobotics Corporation (PRCT)
NASDAQ: PRCT · Real-Time Price · USD
23.54
-0.26 (-1.09%)
At close: Nov 16, 2026, 4:00 PM EST
23.53
-0.01 (-0.04%)
Pre-market: Nov 17, 2026, 7:00 AM EST
PROCEPT BioRobotics Market Cap
PROCEPT BioRobotics has a market cap or net worth of $1.35 billion as of November 16, 2026. It is the 8,260th most valuable company in the world and the 2,009th biggest in the United States. Its market cap has decreased by 18.36% in one year.
Market Cap
1.35B
Enterprise Value
1.21B
1-Year Change
-18.36%
Global Rank
Country Rank
#2,009 United States
Category
ChartMarket Cap Chart
Since the IPO on September 15, 2021, PROCEPT BioRobotics's market cap has increased from $1.06B to $1.35B, an increase of 28.17%. That is a compound annual growth rate of 4.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 16, 2026 | 1.35B | -22.96% |
| Dec 31, 2025 | 1.76B | -59.65% |
| Dec 31, 2024 | 4.36B | 105.85% |
| Dec 29, 2023 | 2.12B | 13.93% |
| Dec 30, 2022 | 1.86B | 70.76% |
| Dec 31, 2021 | 1.09B | 2.94% |
| Sep 15, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Inspire Medical Systems | 1.77B |
| Butterfly Network | 1.63B |
| Enovis | 1.60B |
| CONMED | 1.51B |
| Lumexa Imaging Holdings | 1.42B |
| Tandem Diabetes Care | 1.40B |
| NovoCure | 1.38B |
| Integra LifeSciences Holdings | 1.12B |